🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Announcing the candidates of the 2024 SITC Election, being held May 2-16! SITC members will vote to select the next Vice President and three At-Large Directors. Read the biography and platform statement of each candidate here: sitcancer.org/membership/202…

The #SITC election starts on Thursday! The three At-Large Directors who receive the plurality of votes will begin three-year terms in 2025. Read the biographies and platform statements of this year’s candidates at sitcancer.org/membership/202…

Voting is now OPEN at SITC! I’m running for an At-Large Director position to continue to serve - and now guide - this amazing Society forward. I’d appreciate your support! Society for Immunotherapy of Cancer SITC Early Career Scientist Committee #CIWS #Sparkathon sitcancer.org/membership/202…

The 2024 SITC Election is now open! #SITC members are electing the society’s next Vice President and three At-Large Directors. The election closes on Thursday, May 16 at 11:59 p.m. EDT. sitcancer.org/membership/202…

Massive database of funding opportunities for early-career researchers in any field. For each of the 396 entries (!!), we provide a description of the award, link to funder, eligibility criteria, deadline, and $ amount. Download it here: research.jhu.edu/rdt/funding-op…

Looking forward to presenting, chairing & seeing colleagues in Chicago this Monday for the SITC Session at IMMUNOLOGY2024! Major focus on adoptive cell therapy. Society for Immunotherapy of Cancer Immunology

I’m delighted to be nominated for At-Large Director at Society for Immunotherapy of Cancer, the Premier Society for cancer immunotherapy, & to more deeply contribute to the society. If you are a SITC member, please do vote. The election is now open! #CIWS Parker Institute for Cancer Immunotherapy Penn Medicine - Abramson Cancer Center Penn Medicine

Dr Brian Gastman from Iovance Biotherapeutics kicking off Society for Immunotherapy of Cancer Session at AAI’s #Immunology2024 on Personalized Immunotherapy with a focus on #TILs in melanoma and NSCLC. Durable response is achievable.

Rockstar @immunegirl Kristin Anderson at Society for Immunotherapy of Cancer Session on Personalized Immunotherapy at #AAI #Immunology2024 breaks down TCR gene therapy for cancer. Antigen selection is critical! #TCR #tcell

CARologist extraordinaire @CapitiniMD unravels CAR therapy for hematologic tumors at the Society for Immunotherapy of Cancer Session at #AAI #Immunology2024. Next stop: solid tumors! #CAR

#Immunology2024 is a wrap. Special thanks to #BrianGastman from Iovance Biotherapeutics, @immunegirl of UVA and @CapitiniMD of UW- Madison for their outstanding presentations at the Society for Immunotherapy of Cancer Session. Safe travels.

Day 5. Got vote? Society for Immunotherapy of Cancer

The Society for Immunotherapy of Cancer election is closing this week. I’d be honored to contribute more deeply to the Society but I need YOUR vote to do so. If you haven’t already voted, please do. If you have, please spread the word!! #Sparkathon #CIWS

Now is the time! Society for Immunotherapy of Cancer election closes TOMORROW!! I am excited to contribute more deeply to the Society and need your vote to do that. Please vote! #CIWS #Sparkathon Penn Medicine - Abramson Cancer Center

One narrow licensing deal is done and the therapeutic implication are strong ✅ If you want to inducibly express proton X in a homologous CAR T cell product, check out UniVect.

Get your votes in, folks! Society for Immunotherapy of Cancer We need your support!

The Spring Scientific will take place in San Diego, CA & Virtually! #SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to address challenges. To register, visit: go.sitcancer.org/4fupoc0

SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. sitcancer.org/advocacy/indir…

⁦Jason Luke, MD, FACP⁩ showcases the clinical activity of PRAME TCR gene therapy at ⁦Society for Immunotherapy of Cancer⁩ #Spring Scientific.

The recent work from the lab on mKRAS peptide-specific CAR T cells is now available online. A pipeline of new peptide-centric CARs is now in process. Stay tuned. #CAR #KRAS Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy sciencedirect.com/science/articl…